Last edition
News about Industrial talks
PharmEasy completes acquisition of Medlife
The acquisition which took place in January 2021, was aimed at creating a strong unified platform to accelerate the mission of providing quality healthcare to a larger population
Industrial talks | 26/05/2021 | By Darshana | 393
Bharat Biotech expects WHO emergency listing for Covaxin by July-September 2021
Bharat Biotech stated that it has submitted application for WHO Emergency Use Listing (EUL) for Covaxin, and regulatory approvals are expected in July-September, 2021
Industrial talks | 26/05/2021 | By Darshana | 204
Moderna, Aldevron extends partnership for mRNA vaccine and therapeutic pipeline
Moderna, Inc., a biotechnology company pioneering messenger RNA therapeutics and vaccines, and Aldevron, LLC, the leading provider of high-quality plasmid DNA, mRNA and recombinant proteins necessary for vaccines, gene and cell therapy, gene editing and diagnostic applications, have announced their expanded collaboration in support of the Moderna
Industrial talks | 25/05/2021 | By Darshana | 279
RDIF in discussions on production of Sputnik V for other countries, Dr Reddy's
Dr Reddy's Laboratories, which is in a pact with Russian Direct Investment Fund to sell 125 million people doses (250 million vials) of COVID-19 vaccine Sputnik V in India, is holding parleys with RDIF for acquiring rights for more countries, a senior official of the Indian company said. Dr Reddy's, which had received over two lakh vaccines from RDIF
Industrial talks | 20/05/2021 | By Darshana | 229
Biomay Cooperates with BioNTech to Supply DNA Template for COVID-19 mRNA Vaccine
Biomay, a Vienna based biotech manufacturer, today announced their partnership with BioNTech SE to support the supply chain for manufacturing of the Pfizer-BioNTech COVID-19 mRNA vaccine. Biomay is one of the manufacturers supplying BioNTech with the DNA template for the in-vitro transcription of their mRNA active ingredient
Industrial talks | 19/05/2021 | By Darshana | 326
Shilpa Medicare arm collaborates with Dr Reddy's Labs for production of Sputnik V vaccine
Shilpa Medicare Limited via its wholly owned subsidiary Shilpa Biologicals Private Limited (SBPL), has entered into a 3 year definitive agreement with Dr Reddy's Laboratories Limited (DRL) for production-supply of the Sputnik V vaccine from its integrated biologics R&D cum manufacturing center at Dharwad, Karnataka
Industrial talks | 18/05/2021 | By Darshana | 215
After the announcement by Indian Finance Minister, Nirmala Sitharaman to commit a 137% budget increase for healthcare and a nearly 200% boost for developing the pharma sector instills a high level of optimism in the industry.
Industrial talks | 04/02/2021 | By Hemant | 179
Roche and Regeneron announced today that they are joining forces in the fight against COVID-19 to develop, manufacture and distribute REGN-COV2, Regeneron's investigational antiviral antibody combination, to people around the globe.
Industrial talks | 21/08/2020 | By Darshana | 727
Medtronic to invest Rs. 1,200 crore to expand its R&D centre in Hyderabad
With Hyderabad fast emerging as Indias hub for medical devices manufacturing, the US-based Medtronic has decided to further consolidate its base in India in the medical devices manufacturing sector. As part of this, the company has decided to invest Rs. 1,200 crore to scale up and expand its current R&D centre into a state-of-the-art engineering
Industrial talks | 17/08/2020 | By Darshana | 476
Amazon India unveils e:pharmacy platform in Bengaluru, pilots likely in other cities
The Amazon Pharmacy service has currently opened in Bengaluru. The company plans its foray into other metros thereafter. Customers can now order via its platform: amazon.in all medicines via prescription. In addition nutraceuticals supplements, Ayurveda medicines and medical devices can also be ordered
Industrial talks | 14/08/2020 | By Darshana | 416
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy